All Biotech News

List of articles in category All Biotech News
Title	Published Date
Rentschler Biotechnologie GmbH Announces Transition into a European Corporation Called Rentschler Biopharma SE	10/04/2017
Immatics Receives USD 58 Million in Financing to Develop T-Cell Receptor Based Immunotherapies	10/04/2017
RedHill Biopharma Announces Positive Top-Line Results from Phase II Study of BEKINDA® in Patients with Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)	10/03/2017
Dutch Mellon Medical Secures € 6 Million for Market Introduction of Major Innovation in Surgical Suture Technology: Single-Handed Suturing Using the Switch®	10/02/2017
PnuVax Awarded USD29.4 Million USD Grant to Advance Innovative Vaccine into Clinical Trials	10/02/2017
RedHill Biopharma Accelerates RHB-104 Phase III Study in Crohn’s Disease with Top-Line Results Expected Mid-2018	10/02/2017
Vetter Lays the Foundation for a State-of-the-Art Administration Building	09/28/2017
Swiss Biotech Association Strengthens Its Board of Directors and Appoints Michael Altorfer As Its New CEO	09/27/2017
rfxcel Drives EU Expansion with Industry Experts	09/27/2017
OncoQR ML's Vaccine Platform Closes the Final Gap in the Immunological Attack Against Cancer	09/21/2017
SGI-DNA and BioCat Announce Distribution Partnership for Vmax™ Express Protein Expression Platform	09/20/2017
Molecular Devices and Cytena Partner to Launch the CloneSelect Single-Cell Printer	09/19/2017
Aplagon Partners with Cadila Pharmaceuticals to Develop and Commercialize APAC First-in-Class Antithrombotics for the Prevention of Blood Vessel Occlusions Related to Vascular Interventions	09/19/2017
VarmX Announces Publication in Nature Communications of Groundbreaking Snake Venom Inspired Approach to Restore Blood Clotting in Patients Using Anticoagulants	09/18/2017
New In-situ Hydrolysis SPE Plates from Biotage	09/18/2017
Shuwen Biotech Receives CE Mark for EGFR Mutation PCR Kit for Lung Cancer	09/18/2017
Levicept Starts First-in-Human Phase I Trial of LEVI-04, A Novel Fusion Protein Therapy for Chronic Pain	09/14/2017
Der Sartorius Campus wächst: Einweihung des neuen Produktionsgebäudes für Laborinstrumente	09/13/2017
RedHill Biopharma Initiates Promotion of Esomeprazole Strontium Delayed-Release Capsules 49.3 mg in the U.S.	09/13/2017
European Patent Office Decides in Synthon's Favor in Glatiramer Patent Case	09/13/2017
Invicro Acquires Imanova to Expand Global Imaging Capabilities	09/12/2017
Successful Industrial GMP Manufacturing of RIBOXXIM, a Novel and Highly Potent Toll-like 3 Ligand for Immunotherapy of Cancer	09/12/2017
New Analysis from German Study Group Prospective Trial Shows Minimal Distant Recurrence in Patients with Clinically High-Risk Breast Cancer and Low Oncotype DX Breast Recurrence Score® Results Following Five Years of Hormone Therapy Alone	09/11/2017
Robust Performance of OncoBEAM™ RAS CRC Liquid Biopsy Testing in Routine Clinical Practice for Colorectal Cancer Patients Highlighted at ESMO 2017	09/08/2017
Congenica’s Sapientia™ Selected by Coimbra Paediatric Hospital for Portugal’s In2Genome Genetic Disease Diagnosis Project	09/06/2017
AMAL Therapeutics Raises EUR 8 Million (CHF 8.8 Million) in First Closing of Series B Financing Round	09/05/2017
Asian Study of Over 15,000 Mammograms Underlines the Potential Value of Sigmascreening’s Sensitive Sigma™ Paddle Solution for Pressure Guided Mammography	09/01/2017
Orchard Therapeutics Announces That OTL-101 Has Received a Designation as Promising Innovative Medicine by UK’s Regulatory Agency	08/22/2017
Immatics Initiates Personalized Adoptive Cellular Therapy in Patients with Relapsed And/Or Refractory Solid Cancers Using Its Pioneering Target Warehouse	08/21/2017
RedHill Biopharma Announces U.S. Commercialization Agreement for FDA-Approved GI Product Esomeprazole Strontium Delayed-Release Capsules	08/17/2017

Page 35 of 84